ResFinder 4.0:从基因型预测抗菌药物表型
ResFinder 4.0 通过重写代码、使用Kmer比对、更新数据库并新增基因型-表型关联库和物种特异性药敏板,实现了从全基因组测序数据直接生成体外药敏结果。在多种革兰阴性和阳性菌中验证,基因型-表型一致率在多数组合中≥95%,不一致主要源于表型判读标准或序列质量,而非工具性能。
要点
- ResFinder 4.0 可自动生成体外药敏结果,无需生物信息学技能。
- 对46/51革兰阴性菌和25/32革兰阳性菌组合,一致率≥95%。
- 不一致主要与表型判读标准或序列质量有关,而非工具性能。
核心结论
- 基于ResFinder 4.0的全基因组测序药敏试验,至少对主要公共卫生相关的细菌/抗菌药物组合,可提供与表型药敏同样可靠的体外药敏结果。
研究设计与样本
- 研究重写ResFinder代码以处理原始reads并使用Kmer比对,更新和扩展ResFinder与PointFinder数据库,新增基因型-表型关联库和物种特异性药敏板,并用大肠杆菌(n=584)、沙门菌属(n=1081)、空肠弯曲菌(n=239)、屎肠球菌(n=106)、粪肠球菌(n=50)和金黄色葡萄球菌(n=163)进行验证。
主要发现
- 在评估的革兰阴性菌抗菌药物/物种组合中,46/51的组合基因型-表型一致率≥95%。
- 在评估的革兰阳性菌抗菌药物/物种组合中,25/32的组合基因型-表型一致率≥95%。
- 当一致率<95%时,不一致主要与表型试验判读标准和次优序列质量有关,而非ResFinder 4.0的性能。
临床怎么用
- 临床微生物实验室可利用ResFinder 4.0从全基因组测序数据快速生成体外药敏结果,辅助抗菌药物敏感性试验。
- 该工具可帮助无生物信息学背景的用户解读耐药基因型与表型的关联。
局限性
- 研究未报告ResFinder 4.0在其它细菌/抗菌药物组合中的性能。
- 不一致案例与表型判读标准和序列质量相关,提示需关注这些因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: WGS-based antimicrobial susceptibility testing (AST) is as reliable as phenotypic AST for several antimicrobial/bacterial species combinations. However, routine use of WGS-based AST is hindered by the need for bioinformatics skills and knowledge of antimicrobial resistance (AMR) determinants to operate the vast majority of tools developed to date. By leveraging on ResFinder and PointFinder, two freely accessible tools that can also assist users without bioinformatics skills, we aimed at increasing their speed and providing an easily interpretable antibiogram as output. METHODS: The ResFinder code was re-written to process raw reads and use Kmer-based alignment. The existing ResFinder and PointFinder databases were revised and expanded. Additional databases were developed including a genotype-to-phenotype key associating each AMR determinant with a phenotype at the antimicrobial compound level, and species-specific panels for in silico antibiograms. ResFinder 4.0 was validated using Escherichia coli (n = 584), Salmonella spp. (n = 1081), Campylobacter jejuni (n = 239), Enterococcus faecium (n = 106), Enterococcus faecalis (n = 50) and Staphylococcus aureus (n = 163) exhibiting different AST profiles, and from different human and animal sources and geographical origins. RESULTS: Genotype-phenotype concordance was ≥95% for 46/51 and 25/32 of the antimicrobial/species combinations evaluated for Gram-negative and Gram-positive bacteria, respectively. When genotype-phenotype concordance was <95%, discrepancies were mainly linked to criteria for interpretation of phenotypic tests and suboptimal sequence quality, and not to ResFinder 4.0 performance. CONCLUSIONS: WGS-based AST using ResFinder 4.0 provides in silico antibiograms as reliable as those obtained by phenotypic AST at least for the bacterial species/antimicrobial agents of major public health relevance considered.
引用
- Bortolaia V, Kaas RS, Ruppe E, et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother. 2020. PMID: 32780112. doi:10.1093/jac/dkaa345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。